ENDOMETRIAL CARCINOMA
Clinical trials for ENDOMETRIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL CARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a third chemo drug tame advanced endometrial cancer?
Disease control CompletedThis study looked at whether adding a drug called epirubicin to the standard two-drug chemotherapy (paclitaxel and carboplatin) helps people with advanced endometrial cancer. Sixty patients were enrolled to see if the three-drug combo is better at controlling the disease before s…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: NA • Sponsor: Sohag University • Aim: Disease control
Last updated Jun 22, 2026 11:57 UTC
-
New combo therapy shows promise for Tough-to-Treat endometrial cancer
Disease control CompletedThis study tested whether a combination of two drugs, pembrolizumab and lenvatinib, works better than standard chemotherapy for women with advanced or recurrent endometrial cancer. About 842 women with stage III, IV, or recurrent disease took part. The goal was to see if the comb…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 18, 2026 11:46 UTC
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control CompletedThis study tested a new immunotherapy drug, ezabenlimab, combined with other cancer medicines in 211 adults with advanced solid tumors that had spread. The goal was to see if the tumors shrank or disappeared. Participants received different drug combinations, and doctors monitore…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 17, 2026 12:06 UTC
-
New drug cocktail shows promise for Tough-to-Treat uterine cancer
Disease control CompletedThis study tested a combination of three drugs (bevacizumab, atezolizumab, and rucaparib) in 30 people with endometrial cancer that had come back or continued to grow despite prior treatment. The goal was to see how many participants' tumors shrank or disappeared. The approach ai…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
Universal DNA screening in endometrial cancer reveals hidden genetic risks
Knowledge-focused CompletedThis study tested over 1,000 women with endometrial cancer for DNA repair problems that can be inherited (Lynch syndrome). By analyzing tumor DNA, researchers aimed to personalize cancer treatment and identify family members who might also be at risk. The goal was to improve care…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:08 UTC
-
Scientists probe muscle metabolism in cancer patients with unexplained weight loss
Knowledge-focused CompletedThis study looked at how muscle cells produce energy in women with ovarian or endometrial cancer who have lost weight. Researchers compared women with different body mass indexes (BMI) to see if metabolism differs. The goal was to understand the biology behind cancer-related weig…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: NA • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:08 UTC